BreathIN is pioneering respiratory care through groundbreaking implantable ventilator technology, designed to fundamentally transform the lives of ventilator-dependent patients.

Today,  Mechanical ventilation is essential for patients with degenerative diseases, cervical trauma, or prolonged respiratory failure. Current external ventilators significantly impact patient quality of life, causing severe complications, including loss of speech, repeated hospitalizations, restricted mobility, and progressive muscle weakness. Additionally, these traditional solutions carry high financial burdens, averaging ~$450,000 per patient over three years.
BreathIN's Solution, the Airflow1000 is an innovative Negative Pressure Implantable Ventilator that closely mimics the body's natural breathing mechanism.

Key Benefits:
•	Enhanced Quality of Life: Liberates patients from external ventilators, restoring mobility and significantly improving life quality.
•	Unique Operational Modes: Adaptive autonomic regulation with specialized "Speaking" and "Coughing" modes, enabling natural interaction.
•	Infection Reduction: Minimally invasive implantation eliminates the need for tracheostomy, reducing infection risks.
•	Cost-Efficiency: Cuts ventilation costs by up to 55%, saving substantial healthcare expenditures.
Market Opportunity:
•	Over 500,000 potential patients in the US alone.
•	Each patient presents a ~$450k three-year expenditure; Airflow1000 significantly reduces these costs.

BreathIN

Org chart

Teams

Offices